Search Results - "Naldini, A"

Refine Results
  1. 1

    Carbonic anhydrase XII expression is linked to suppression of Sonic hedgehog ligand expression in triple negative breast cancer cells by Guerrini, G., Durivault, J., Filippi, I., Criscuoli, M., Monaci, S., Pouyssegur, J., Naldini, A., Carraro, F., Parks, S.K.

    “…Aberrant activity of the hedgehog (Hh) pathway is prevalent in pathologies such as cancer. Improved understanding of Hh activity in the aggressive tumor cell…”
    Get full text
    Journal Article
  2. 2

    Indocyanine green fluorescence applied to gynecologic oncology: beyond sentinel lymph node by Loverro, M, Bizzarri, N, Capomacchia, F M, Watrowski, Rafał, Querleu, D, Gioè, A, Naldini, A, Santullo, F, Foschi, N, Fagotti, A, Scambia, G, Fanfani, F

    “…Indocyanine green (ICG), a well-known molecule employed in medicine for over five decades, has emerged as a versatile dye widely embraced across various…”
    Get full text
    Journal Article
  3. 3

    Role of the hypoxic microenvironment in the antitumor activity of tyrosine kinase inhibitors by Filippi, I, Naldini, A, Carraro, F

    Published in Current medicinal chemistry (01-06-2011)
    “…The tumor microenvironment is characterized, not only by marked gradients in drug concentration, but also by gradients in the rate of cell proliferation and by…”
    Get more information
    Journal Article
  4. 4

    Secondary cytoreduction plus oxaliplatin-based HIPEC in platinum-sensitive recurrent ovarian cancer patients: A pilot study by Fagotti, A, Paris, I, Grimolizzi, F, Fanfani, F, Vizzielli, G, Naldini, A, Scambia, G

    Published in Gynecologic oncology (01-06-2009)
    “…Abstract Objectives To assess feasibility, complications and efficacy of secondary surgical cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Analysis of protease-activated receptor-1 and -2 in human scar formation by Materazzi, S, Pellerito, S, Di Serio, C, Paglierani, M, Naldini, A, Ardinghi, C, Carraro, F, Geppetti, P, Cirino, G, Santucci, M, Tarantini, F, Massi, D

    Published in The Journal of pathology (01-08-2007)
    “…Protease‐activated receptor (PAR)‐1 and PAR‐2 are reported to contribute to the fibrotic process in a number of organs, including lung, liver, pancreas, and…”
    Get full text
    Journal Article
  7. 7

    New pyrazolo[3,4- d]pyrimidines endowed with A431 antiproliferative activity and inhibitory properties of Src phosphorylation by Schenone, S., Bruno, O., Ranise, A., Bondavalli, F., Brullo, C., Fossa, P., Mosti, L., Menozzi, G., Carraro, F., Naldini, A., Bernini, C., Manetti, F., Botta, M.

    Published in Bioorganic & medicinal chemistry letters (17-05-2004)
    “…New 4-aminopyrazolo[3,4- d]pyrimidines substituted in positions 1 and 6 have been reported. Compounds showed A431 antiproliferative activity and inhibition of…”
    Get full text
    Journal Article
  8. 8

    Role of different approaches to the abdominal retroperitoneum for aortic lymphadenectomy in patients with gynecological cancers by Ercoli, A, Fanfani, F, D'Asta, M, Naldini, A, Pacelli, F, Scambia, G, Fagotti, A

    Published in European journal of surgical oncology (01-01-2013)
    “…Abstract Background Paraaortic lymphadenectomy (PALN) is a standard part of many interventions, but currently there are no established care protocols effective…”
    Get full text
    Journal Article
  9. 9

    Regulation of angiogenesis by Th1- and Th2-type cytokines by Naldini, A, Pucci, A, Bernini, C, Carraro, F

    Published in Current pharmaceutical design (01-01-2003)
    “…Angiogenesis is a complex process, where several cell types and mediators interact to establish a specific microenvironment suitable for the formation of new…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Inhibition of interleukin‐12 expression by α‐thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses by Naldini, A, Aarden, L, Pucci, A, Bernini, C, Carraro, F

    Published in British journal of pharmacology (01-11-2003)
    “…In addition to its central role in blood coagulation and hemostasis, human α‐thrombin is a powerful regulator of inflammatory responses and is known to affect…”
    Get full text
    Journal Article
  12. 12

    Phase II study of pegylated liposomal doxorubicin in heavily pretreated epithelial ovarian cancer patients. May a new treatment schedule improve toxicity profile? by Lorusso, D, Naldini, A, Testa, A, D'Agostino, G, Scambia, G, Ferrandina, G

    Published in Oncology (01-01-2004)
    “…Pegylated liposomal doxorubicin (PLD) has shown promising activity in the treatment of recurrent ovarian cancer but skin toxicity remains the dose-limiting…”
    Get more information
    Journal Article
  13. 13

    Endometrioid adenocarcinoma with squamous differentiation arising from ureteral endometriosis in a patient with no history of gonadal endometriosis by Salerno, M.G., Masciullo, V., Naldini, A., Zannoni, G.F., Vellone, V., Scambia, G.

    Published in Gynecologic oncology (01-12-2005)
    “…Malignant transformation may occur in up to 1% of women with endometriosis and only 20% of these cases occur at extragonadal pelvic sites. Similarly, urinary…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16

    The new surgical robot Hugo™ RAS for total hysterectomy: a pilot study by Monterossi, G, Pedone Anchora, L, Oliva, R, Fagotti, A, Fanfani, F, Costantini, B, Naldini, A, Giannarelli, D, Scambia, G

    Published in Facts, views & vision in ObGyn (01-12-2023)
    “…With the rising popularity of robotic surgery, Hugo™ RAS is one of the newest surgical robotic platforms. Investigating the reliability of this tool is the…”
    Get full text
    Journal Article
  17. 17

    Heparin coating of extracorporeal circuits inhibits cytokine release from mononuclear cells during cardiac operations by Giomarelli, P, Naldini, A, Biagioli, B, Borrelli, E

    Published in International journal of artificial organs (01-04-2000)
    “…To evaluate whether the production of interleukin 2 (IL 2), interleukin 6 (IL 6) and interleukin 10 (IL 10) from stimulated peripheral blood mononuclear cells…”
    Get full text
    Journal Article
  18. 18

    Identification of thrombin-like activity in ovarian cancer associated ascites and modulation of multiple cytokine networks by Naldini, Antonella, Morena, Emilia, Belotti, Dorina, Carraro, Fabio, Allavena, Paola, Giavazzi, Raffaella

    Published in Thrombosis and haemostasis (01-10-2011)
    “…Blood coagulation cascades can be activated by different mechanisms and to different levels in cancer patients. In a study conducted on the transcriptional…”
    Get more information
    Journal Article
  19. 19

    Plasma levels of immunosuppressive mediators during cardiopulmonary bypass by Borrelli, E, Giomarelli, P, Naldini, A, Luzzi, E, Silvestri, S, Gardinali, M, Bocci, V

    Published in Mediators of Inflammation (1996)
    “…THE aim of this study was to evaluate plasma levels of two mediators with immunosuppressive properties, complement fraction C3a (C3a) and transforming growth…”
    Get full text
    Journal Article
  20. 20